» Articles » PMID: 10867333

Early Alterations of Myocardial Blood Flow Reserve in Heart Transplant Recipients with Angiographically Normal Coronary Arteries

Overview
Publisher Elsevier
Date 2000 Jun 27
PMID 10867333
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The evaluation of the coronary reserve provides valuable information on the status of coronary vessels. Therefore, we studied with positron emission tomography (PET) and 13N-ammonia the myocardial blood flow (MBF) reserve in heart transplant recipients free of allograft rejection and with angiographically normal coronary arteries early after heart transplantation (HTx). The MBF reserve was calculated as the ratio between MBF after dipyridamole injection and basal MBF normalized for the rate-pressure product.

Methods: Patients were studied within 3 months (group A, n = 12) or more than 9 months (group B, n = 12) after HTx. Five patients have been studied both during the early and late period after HTx. Results were compared to those obtained in 7 normal volunteers (NL).

Results: Group A recipients had a significantly lower dipyridamole MBF (in ml/min/100 gr of tissue) than that of group B recipients (142+/-34 vs 195+/-59, p<0.05). This resulted in a significant decrease in MBF reserve early after HTx (group A: 1.82+/- 0.33) and a restoration to normal values thereafter (group B: 2.52+/- 0.53 vs NL: 2.62+/-0.51, p = ns). Separate analysis of 5 patients studied twice is consistent with these results.

Conclusion: This study shows that in heart transplant recipients free of allograft rejection and with normal coronary angiography, MBF reserve is impaired early after HTx. Restoration within one year suggests that this abnormality does not represent an early stage of cardiac allograft vasculopathy.

Citing Articles

Cardiac Allograft Vasculopathy: Challenges and Advances in Invasive and Non-Invasive Diagnostic Modalities.

Kamel M, Scalia I, Badr A, Baba Ali N, Farina J, Pereyra M J Cardiovasc Dev Dis. 2024; 11(3).

PMID: 38535118 PMC: 10971179. DOI: 10.3390/jcdd11030095.


Myocardial perfusion reserve and global longitudinal strain as potential markers of coronary allograft vasculopathy in late-stage orthotopic heart transplantation.

Narang A, Blair J, Patel M, Mor-Avi V, Fedson S, Uriel N Int J Cardiovasc Imaging. 2018; 34(10):1607-1617.

PMID: 29728952 PMC: 6160357. DOI: 10.1007/s10554-018-1364-7.


Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.

Murthy V, Bateman T, Beanlands R, Berman D, Borges-Neto S, Chareonthaitawee P J Nucl Cardiol. 2017; 25(1):269-297.

PMID: 29243073 DOI: 10.1007/s12350-017-1110-x.


Noninvasive PET quantitative myocardial blood flow with regadenoson for assessing cardiac allograft vasculopathy in orthotopic heart transplantation patients.

Hernandez Pampaloni M, Shrestha U, Sciammarella M, Seo Y, Gullberg G, Botvinick E J Nucl Cardiol. 2017; 24(4):1134-1144.

PMID: 28138813 PMC: 5534390. DOI: 10.1007/s12350-016-0761-3.


Transplant allograft vasculopathy: Role of multimodality imaging in surveillance and diagnosis.

Payne G, Hage F, Acharya D J Nucl Cardiol. 2015; 23(4):713-27.

PMID: 26711101 DOI: 10.1007/s12350-015-0373-3.